Request Sample Inquiry
Nanomedicine Market

Nanomedicine Market

Nanomedicine Market - Global Industry Assessment & Forecast

img
Healthcare
Number Of Pages # Pages:

149

Base Year:

2022

Date

Jun - 2022

Format:

PDF XLS PPT

Report Code:

VMR-1632

Segments Covered
  • By Modality By Modality Diagnostics, Treatment
  • By Application By Application Drug Delivery, Diagnostic Imaging, Vaccines, Regenerative Medicine, Implants, Others
  • By Indication By Indication Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopedics, Neurology, Urology, Ophthalmology, Immunology, Others
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 188.05 Billion
Revenue 2030Revenue 2030: USD 366.53 Billion
Revenue CAGRRevenue CAGR (2023 - 2030): 8.70%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Nanomedicine Market - Segment Analysis
    1. Overview
    2. Global Nanomedicine Market, 2016 - 2028 (USD Million)
    3. Global Nanomedicine Market - by Modality
      1. By Diagnostics
      2. By Treatment
    4. Global Nanomedicine Market - by Application
      1. By Drug Delivery
      2. By Diagnostic Imaging
      3. By Vaccines
      4. By Regenerative Medicine
      5. By Implants
      6. By Others
    5. Global Nanomedicine Market - by Indication
      1. By Clinical Oncology
      2. By Infectious Diseases
      3. By Clinical Cardiology
      4. By Orthopedics
      5. By Neurology
      6. By Urology
      7. By Ophthalmology
      8. By Immunology
      9. By Others
    6. Global Nanomedicine Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    7. Market comparative analysis
  4. North America Nanomedicine Market - Segment Analysis
    1. Overview
    2. North America Nanomedicine Market, 2016 - 2028 (USD Million)
    3. North America Nanomedicine Market, by Modality
      1. By Diagnostics
      2. By Treatment
    4. North America Nanomedicine Market, by Application
      1. By Drug Delivery
      2. By Diagnostic Imaging
      3. By Vaccines
      4. By Regenerative Medicine
      5. By Implants
      6. By Others
    5. North America Nanomedicine Market, by Indication
      1. By Clinical Oncology
      2. By Infectious Diseases
      3. By Clinical Cardiology
      4. By Orthopedics
      5. By Neurology
      6. By Urology
      7. By Ophthalmology
      8. By Immunology
      9. By Others
    6. North America Nanomedicine Market, by Country
      1. U.S.
        1. U.S. Nanomedicine Market, By Modality
          1. By Diagnostics
          2. By Treatment
        2. U.S. Nanomedicine Market, By Application
          1. By Drug Delivery
          2. By Diagnostic Imaging
          3. By Vaccines
          4. By Regenerative Medicine
          5. By Implants
          6. By Others
        3. U.S. Nanomedicine Market, By Indication
          1. By Clinical Oncology
          2. By Infectious Diseases
          3. By Clinical Cardiology
          4. By Orthopedics
          5. By Neurology
          6. By Urology
          7. By Ophthalmology
          8. By Immunology
          9. By Others
      2. Canada
        1. Canada Nanomedicine Market, By Modality
          1. By Diagnostics
          2. By Treatment
        2. Canada Nanomedicine Market, By Application
          1. By Drug Delivery
          2. By Diagnostic Imaging
          3. By Vaccines
          4. By Regenerative Medicine
          5. By Implants
          6. By Others
        3. Canada Nanomedicine Market, By Indication
          1. By Clinical Oncology
          2. By Infectious Diseases
          3. By Clinical Cardiology
          4. By Orthopedics
          5. By Neurology
          6. By Urology
          7. By Ophthalmology
          8. By Immunology
          9. By Others
      3. Mexico
        1. Mexico Nanomedicine Market, By Modality
          1. By Diagnostics
          2. By Treatment
        2. Mexico Nanomedicine Market, By Application
          1. By Drug Delivery
          2. By Diagnostic Imaging
          3. By Vaccines
          4. By Regenerative Medicine
          5. By Implants
          6. By Others
        3. Mexico Nanomedicine Market, By Indication
          1. By Clinical Oncology
          2. By Infectious Diseases
          3. By Clinical Cardiology
          4. By Orthopedics
          5. By Neurology
          6. By Urology
          7. By Ophthalmology
          8. By Immunology
          9. By Others
  5. Europe Nanomedicine Market - Segment Analysis
    1. Overview
    2. Europe Nanomedicine Market, 2016 - 2028 (USD Million)
    3. Europe Nanomedicine Market, by Modality
      1. By Diagnostics
      2. By Treatment
    4. Europe Nanomedicine Market, by Application
      1. By Drug Delivery
      2. By Diagnostic Imaging
      3. By Vaccines
      4. By Regenerative Medicine
      5. By Implants
      6. By Others
    5. Europe Nanomedicine Market, by Indication
      1. By Clinical Oncology
      2. By Infectious Diseases
      3. By Clinical Cardiology
      4. By Orthopedics
      5. By Neurology
      6. By Urology
      7. By Ophthalmology
      8. By Immunology
      9. By Others
    6. Europe Nanomedicine Market, by Country
      1. Germany
        1. Germany Nanomedicine Market, By Modality
          1. By Diagnostics
          2. By Treatment
        2. Germany Nanomedicine Market, By Application
          1. By Drug Delivery
          2. By Diagnostic Imaging
          3. By Vaccines
          4. By Regenerative Medicine
          5. By Implants
          6. By Others
        3. Germany Nanomedicine Market, By Indication
          1. By Clinical Oncology
          2. By Infectious Diseases
          3. By Clinical Cardiology
          4. By Orthopedics
          5. By Neurology
          6. By Urology
          7. By Ophthalmology
          8. By Immunology
          9. By Others
      2. UK
        1. UK Market, By Modality
          1. By Diagnostics
          2. By Treatment
        2. UK Market, By Application
          1. By Drug Delivery
          2. By Diagnostic Imaging
          3. By Vaccines
          4. By Regenerative Medicine
          5. By Implants
          6. By Others
        3. UK Market, By Indication
          1. By Clinical Oncology
          2. By Infectious Diseases
          3. By Clinical Cardiology
          4. By Orthopedics
          5. By Neurology
          6. By Urology
          7. By Ophthalmology
          8. By Immunology
          9. By Others
      3. France
        1. France Nanomedicine Market, By Modality
          1. By Diagnostics
          2. By Treatment
        2. France Nanomedicine Market, By Application
          1. By Drug Delivery
          2. By Diagnostic Imaging
          3. By Vaccines
          4. By Regenerative Medicine
          5. By Implants
          6. By Others
        3. France Nanomedicine Market, By Indication
          1. By Clinical Oncology
          2. By Infectious Diseases
          3. By Clinical Cardiology
          4. By Orthopedics
          5. By Neurology
          6. By Urology
          7. By Ophthalmology
          8. By Immunology
          9. By Others
      4. Spain
        1. Spain Nanomedicine Market, By Modality
          1. By Diagnostics
          2. By Treatment
        2. Spain Nanomedicine Market, By Application
          1. By Drug Delivery
          2. By Diagnostic Imaging
          3. By Vaccines
          4. By Regenerative Medicine
          5. By Implants
          6. By Others
        3. Spain Nanomedicine Market, By Indication
          1. By Clinical Oncology
          2. By Infectious Diseases
          3. By Clinical Cardiology
          4. By Orthopedics
          5. By Neurology
          6. By Urology
          7. By Ophthalmology
          8. By Immunology
          9. By Others
      5. Italy
        1. Italy Nanomedicine Market, By Modality
          1. By Diagnostics
          2. By Treatment
        2. Italy Nanomedicine Market, By Application
          1. By Drug Delivery
          2. By Diagnostic Imaging
          3. By Vaccines
          4. By Regenerative Medicine
          5. By Implants
          6. By Others
        3. Italy Nanomedicine Market, By Indication
          1. By Clinical Oncology
          2. By Infectious Diseases
          3. By Clinical Cardiology
          4. By Orthopedics
          5. By Neurology
          6. By Urology
          7. By Ophthalmology
          8. By Immunology
          9. By Others
      6. BENELUX
        1. BENELUX Nanomedicine Market, By Modality
          1. By Diagnostics
          2. By Treatment
        2. BENELUX Nanomedicine Market, By Application
          1. By Drug Delivery
          2. By Diagnostic Imaging
          3. By Vaccines
          4. By Regenerative Medicine
          5. By Implants
          6. By Others
        3. BENELUX Nanomedicine Market, By Indication
          1. By Clinical Oncology
          2. By Infectious Diseases
          3. By Clinical Cardiology
          4. By Orthopedics
          5. By Neurology
          6. By Urology
          7. By Ophthalmology
          8. By Immunology
          9. By Others
      7. Rest of Europe
        1. Rest Of Europe Nanomedicine Market, By Modality
          1. By Diagnostics
          2. By Treatment
        2. Rest Of Europe Nanomedicine Market, By Application
          1. By Drug Delivery
          2. By Diagnostic Imaging
          3. By Vaccines
          4. By Regenerative Medicine
          5. By Implants
          6. By Others
        3. Rest Of Europe Nanomedicine Market, By Indication
          1. By Clinical Oncology
          2. By Infectious Diseases
          3. By Clinical Cardiology
          4. By Orthopedics
          5. By Neurology
          6. By Urology
          7. By Ophthalmology
          8. By Immunology
          9. By Others
  6. Asia Pacific Nanomedicine Market - Segment Analysis
    1. Overview
    2. Asia Pacific Nanomedicine Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Nanomedicine Market, by Modality
      1. By Diagnostics
      2. By Treatment
    4. Asia Pacific Nanomedicine Market, by Application
      1. By Drug Delivery
      2. By Diagnostic Imaging
      3. By Vaccines
      4. By Regenerative Medicine
      5. By Implants
      6. By Others
    5. Asia Pacific Nanomedicine Market, by Indication
      1. By Clinical Oncology
      2. By Infectious Diseases
      3. By Clinical Cardiology
      4. By Orthopedics
      5. By Neurology
      6. By Urology
      7. By Ophthalmology
      8. By Immunology
      9. By Others
    6. Asia Pacific Nanomedicine Market, by Country
      1. China
        1. China Nanomedicine Market, By Modality
          1. By Diagnostics
          2. By Treatment
        2. China Nanomedicine Market, By Application
          1. By Drug Delivery
          2. By Diagnostic Imaging
          3. By Vaccines
          4. By Regenerative Medicine
          5. By Implants
          6. By Others
        3. China Nanomedicine Market, By Indication
          1. By Clinical Oncology
          2. By Infectious Diseases
          3. By Clinical Cardiology
          4. By Orthopedics
          5. By Neurology
          6. By Urology
          7. By Ophthalmology
          8. By Immunology
          9. By Others
      2. Japan
        1. Japan Nanomedicine Market, By Modality
          1. By Diagnostics
          2. By Treatment
        2. Japan Nanomedicine Market, By Application
          1. By Drug Delivery
          2. By Diagnostic Imaging
          3. By Vaccines
          4. By Regenerative Medicine
          5. By Implants
          6. By Others
        3. Japan Nanomedicine Market, By Indication
          1. By Clinical Oncology
          2. By Infectious Diseases
          3. By Clinical Cardiology
          4. By Orthopedics
          5. By Neurology
          6. By Urology
          7. By Ophthalmology
          8. By Immunology
          9. By Others
      3. India
        1. India Nanomedicine Market, By Modality
          1. By Diagnostics
          2. By Treatment
        2. India Nanomedicine Market, By Application
          1. By Drug Delivery
          2. By Diagnostic Imaging
          3. By Vaccines
          4. By Regenerative Medicine
          5. By Implants
          6. By Others
        3. India Nanomedicine Market, By Indication
          1. By Clinical Oncology
          2. By Infectious Diseases
          3. By Clinical Cardiology
          4. By Orthopedics
          5. By Neurology
          6. By Urology
          7. By Ophthalmology
          8. By Immunology
          9. By Others
      4. South Korea
        1. South Korea Nanomedicine Market, By Modality
          1. By Diagnostics
          2. By Treatment
        2. South Korea Nanomedicine Market, By Application
          1. By Drug Delivery
          2. By Diagnostic Imaging
          3. By Vaccines
          4. By Regenerative Medicine
          5. By Implants
          6. By Others
        3. South Korea Nanomedicine Market, By Indication
          1. By Clinical Oncology
          2. By Infectious Diseases
          3. By Clinical Cardiology
          4. By Orthopedics
          5. By Neurology
          6. By Urology
          7. By Ophthalmology
          8. By Immunology
          9. By Others
      5. South East Asia
        1. South East Asia Nanomedicine Market, By Modality
          1. By Diagnostics
          2. By Treatment
        2. South East Asia Nanomedicine Market, By Application
          1. By Drug Delivery
          2. By Diagnostic Imaging
          3. By Vaccines
          4. By Regenerative Medicine
          5. By Implants
          6. By Others
        3. South East Asia Nanomedicine Market, By Indication
          1. By Clinical Oncology
          2. By Infectious Diseases
          3. By Clinical Cardiology
          4. By Orthopedics
          5. By Neurology
          6. By Urology
          7. By Ophthalmology
          8. By Immunology
          9. By Others
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Nanomedicine Market, By Modality
          1. By Diagnostics
          2. By Treatment
        2. Rest of Asia Pacific Nanomedicine Market, By Application
          1. By Drug Delivery
          2. By Diagnostic Imaging
          3. By Vaccines
          4. By Regenerative Medicine
          5. By Implants
          6. By Others
        3. Rest of Asia Pacific Nanomedicine Market, By Indication
          1. By Clinical Oncology
          2. By Infectious Diseases
          3. By Clinical Cardiology
          4. By Orthopedics
          5. By Neurology
          6. By Urology
          7. By Ophthalmology
          8. By Immunology
          9. By Others
  7. Latin America Nanomedicine Market - Segment Analysis
    1. Overview
    2. Latin America Nanomedicine Market, 2016 - 2028 (USD Million)
    3. Latin America Nanomedicine Market, by Modality
      1. By Diagnostics
      2. By Treatment
    4. Latin America Nanomedicine Market, by Application
      1. By Drug Delivery
      2. By Diagnostic Imaging
      3. By Vaccines
      4. By Regenerative Medicine
      5. By Implants
      6. By Others
    5. Latin America Nanomedicine Market, by Indication
      1. By Clinical Oncology
      2. By Infectious Diseases
      3. By Clinical Cardiology
      4. By Orthopedics
      5. By Neurology
      6. By Urology
      7. By Ophthalmology
      8. By Immunology
      9. By Others
    6. Latin America Nanomedicine Market, by Country
      1. Brazil
        1. Brazil Nanomedicine Market, By Modality
          1. By Diagnostics
          2. By Treatment
        2. Brazil Nanomedicine Market, By Application
          1. By Drug Delivery
          2. By Diagnostic Imaging
          3. By Vaccines
          4. By Regenerative Medicine
          5. By Implants
          6. By Others
        3. Brazil Nanomedicine Market, By Indication
          1. By Clinical Oncology
          2. By Infectious Diseases
          3. By Clinical Cardiology
          4. By Orthopedics
          5. By Neurology
          6. By Urology
          7. By Ophthalmology
          8. By Immunology
          9. By Others
      2. Argentina
        1. Argentina Nanomedicine Market, By Modality
          1. By Diagnostics
          2. By Treatment
        2. Argentina Nanomedicine Market, By Application
          1. By Drug Delivery
          2. By Diagnostic Imaging
          3. By Vaccines
          4. By Regenerative Medicine
          5. By Implants
          6. By Others
        3. Argentina Nanomedicine Market, By Indication
          1. By Clinical Oncology
          2. By Infectious Diseases
          3. By Clinical Cardiology
          4. By Orthopedics
          5. By Neurology
          6. By Urology
          7. By Ophthalmology
          8. By Immunology
          9. By Others
      3. Rest of Latin America
        1. Rest of Latin America Nanomedicine Market, By Modality
          1. By Diagnostics
          2. By Treatment
        2. Rest of Latin America Nanomedicine Market, By Application
          1. By Drug Delivery
          2. By Diagnostic Imaging
          3. By Vaccines
          4. By Regenerative Medicine
          5. By Implants
          6. By Others
        3. Rest of Latin America Nanomedicine Market, By Indication
          1. By Clinical Oncology
          2. By Infectious Diseases
          3. By Clinical Cardiology
          4. By Orthopedics
          5. By Neurology
          6. By Urology
          7. By Ophthalmology
          8. By Immunology
          9. By Others
  8. Middle East & Africa Nanomedicine Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Nanomedicine Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Nanomedicine Market, by Modality
      1. By Diagnostics
      2. By Treatment
    4. Middle East & Africa Nanomedicine Market, by Application
      1. By Drug Delivery
      2. By Diagnostic Imaging
      3. By Vaccines
      4. By Regenerative Medicine
      5. By Implants
      6. By Others
    5. Middle East & Africa Nanomedicine Market, by Indication
      1. By Clinical Oncology
      2. By Infectious Diseases
      3. By Clinical Cardiology
      4. By Orthopedics
      5. By Neurology
      6. By Urology
      7. By Ophthalmology
      8. By Immunology
      9. By Others
    6. Middle East & Africa Nanomedicine Market, by Country
      1. GCC Countries
        1. GCC Countries Nanomedicine Market, By Modality
          1. By Diagnostics
          2. By Treatment
        2. GCC Countries Nanomedicine Market, By Application
          1. By Drug Delivery
          2. By Diagnostic Imaging
          3. By Vaccines
          4. By Regenerative Medicine
          5. By Implants
          6. By Others
        3. GCC Countries Nanomedicine Market, By Indication
          1. By Clinical Oncology
          2. By Infectious Diseases
          3. By Clinical Cardiology
          4. By Orthopedics
          5. By Neurology
          6. By Urology
          7. By Ophthalmology
          8. By Immunology
          9. By Others
      2. South Africa
        1. South Africa Nanomedicine Market, By Modality
          1. By Diagnostics
          2. By Treatment
        2. South Africa Nanomedicine Market, By Application
          1. By Drug Delivery
          2. By Diagnostic Imaging
          3. By Vaccines
          4. By Regenerative Medicine
          5. By Implants
          6. By Others
        3. South Africa Nanomedicine Market, By Indication
          1. By Clinical Oncology
          2. By Infectious Diseases
          3. By Clinical Cardiology
          4. By Orthopedics
          5. By Neurology
          6. By Urology
          7. By Ophthalmology
          8. By Immunology
          9. By Others
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Nanomedicine Market, By Modality
          1. By Diagnostics
          2. By Treatment
        2. Rest of Middle East & Africa Nanomedicine Market, By Application
          1. By Drug Delivery
          2. By Diagnostic Imaging
          3. By Vaccines
          4. By Regenerative Medicine
          5. By Implants
          6. By Others
        3. Rest of Middle East & Africa Nanomedicine Market, By Indication
          1. By Clinical Oncology
          2. By Infectious Diseases
          3. By Clinical Cardiology
          4. By Orthopedics
          5. By Neurology
          6. By Urology
          7. By Ophthalmology
          8. By Immunology
          9. By Others
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. Abbott Laboratories
    2. DiaSorin S.P.A.
    3. General Electric Company
    4. Invitae Corporation
    5. Johnson & Johnson
    6. Leadient BioSciences Inc.
    7. Mallinckrodt PLC
    8. Merck & Co. Inc. Pfizer Inc.
    9. Teva Pharmaceuticals Ltd.
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
Vantage Market Research | 06-Jun-2022
Nanomedicine Market to Reach Valuation of USD 288.7 Billion by 2028 - Increasing Demand for Nanomedicine Market for Drug Delivery, Advantages of Nanomedicine in Various Healthcare Applications, and Growth in Need for Safe and Cost-Effective Therapies to Drive the Market Growth
FAQ
Frequently Asked Question

  • The global Nanomedicine valued at USD 188.05 Billion in 2022 and is expected to reach USD 366.53 Billion in 2030 growing at a CAGR of 8.70%.

  • The prominent players in the market are Abbott Laboratories, DiaSorin S.P.A., General Electric Company, Invitae Corporation, Johnson & Johnson, Leadient BioSciences Inc., Mallinckrodt PLC, Merck & Co. Inc. Pfizer Inc., Teva Pharmaceuticals Ltd..

  • The market is project to grow at a CAGR of 8.70% between 2023 and 2030.

  • The driving factors of the Nanomedicine include

    • Rising level of government participation in R&D funding

  • North America was the leading regional segment of the Nanomedicine in 2022.

Related Reports
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies Privacy Policy